Home | Job-opportunities | Contact | News | Donate
 S'abonner à DNDi_HQ sur Twitter 
Home Diseases Leishmaniasis Portfolio

Portfolio

Attention: open in a new window. PDFPrint


Portfolio

By 2014, DNDi aims to deliver from its VL-specific portfolio:
  • 1 new drug registered
  • 2 geographical extensions in endemic regions outside India by 2014
  • 2 new co-administrations recommended by WHO
  • a robust pipeline



For more details on each project, see DNDi's Global Portfolio

Leishmaniasis



Except where otherwise noted, content on this site is licensed under
a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License